A16AB02 • imiglucerase • Alimentary tract and metabolism | Other alimentary tract and metabolism products | Enzymes
Imiglucerase is a medication used to treat Gaucher disease, a rare genetic disorder caused by a deficiency of the enzyme glucocerebrosidase. It works by replacing the missing enzyme, helping to break down accumulated glucocerebroside in cells and reducing disease symptoms.
The medication is administered via intravenous infusion, usually once every two weeks, under the supervision of a specialist.
Side effects may include infusion site reactions, headache, fever, or fatigue. In rare cases, severe allergic reactions may occur.
Patients should be closely monitored during treatment and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.
Substance: imiglucerase
Date of last drug list: 01-07-2015
Commercial code: W08252001
Concentration: 200U
Pharmaceutical form: powder for concentrate infusion solution
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).